Keros Therapeutics KROS
NASDAQ KROS
$11.18 -0.22 (-1.93%)
At close: Oct 21, 2026 · 4:00 PM EDT

Keros Therapeutics (KROS) Interest Expenses (2019 - 2022)

Updated

Keros Therapeutics' Interest Expenses came in at $1,000 for FY2022, down 75.0% from $4,000 in FY2021.

Analysis

Keros Therapeutics (KROS) Interest Expenses (2019 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put Interest Expenses at $4,000 in FY2021 (-33.3%) and $6,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 281.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 435.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 247.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Keros Therapeutics 221.17 Mn -1.71 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 1,000.00
Mar 31, 2021 1,000.00
Dec 31, 2020 1,000.00
Sep 30, 2020 2,000.00
Jun 30, 2020 1,000.00
Mar 31, 2020 2,000.00
Sep 30, 2019 3,000.00
Jun 30, 2019 2,000.00
Mar 31, 2019 2,000.00
API Access

Keros Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=KROS&period=max&api_key=YOUR_API_KEY